CARSTEN BOESS Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARSTEN BOESS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARSTEN BOESS. CARSTEN BOESS is in ALEXION PHARMACEUTICALS INC ($ALXN) and Vice President & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Chief Financial Officer in SYNAGEVA BIOPHARMA CORP ($GEVA) and in ROCKET PHARMACEUTICALS, INC. ($RCKT) and Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
CARSTEN BOESS in SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CARSTEN BOESS: SVP, Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CARSTEN BOESS in SYNAGEVA BIOPHARMA CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, KNSA, RCKT, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 80.35 | 40,000 | 3,214,000 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 40.74 | 15,938 | 649,314 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 40.32 | 45,000 | 1,814,400 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 23.00 | 7,292 | 167,716 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 1.70 | 9,929 | 16,879 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | D | 0.00 | 24,000 | 0 | 0 | 24 K to 0 (-100.00 %) |
| Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Grant | A | 0.00 | 24,000 | 0 | 24,000 | 0 to 24 K |
Page: 1